An interdisciplinary team of researchers from the University of Illinois has discovered a potential new treatment option for drug-resistant breast cancer. Their findings, published in Breast Cancer Research and Treatment, demonstrates the role of activators of ferroptosis in overcoming acquired resistance to FOXM1 inhibitors.
